Verastem is Biotechnology in United States that focus on chronic lymphocytic leukemia business. Founded in 2010. They cover business area such as Verastem Inc, drug, patient, cancer, COPIKTRA, (duvelisib, at least two prior therapy, refractory follicular lymphoma, at least two prior systemic therapy, defactinib, inhibitor, development, limited treatment option, lung, ovarian.
2010
( 14 years old in 2024 )
Chronic Lymphocytic Leukemia
-
117 Kendrick Street
Suite 500
Needham, MA 02494
United States
Private
Verastem IncdrugpatientcancerCOPIKTRA(duvelisibat least two prior therapyrefractory follicular lymphomaat least two prior systemic therapydefactinibinhibitordevelopmentlimited treatment optionlungovarian
* We use standard office opening hours in near Verastem's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Verastem is Biotechnology business from United States that founded in 2010 (14 years old in 2024), Verastem business is focusing on Chronic Lymphocytic Leukemia.
Verastem headquarter office and corporate office address is located in 117 Kendrick Street Suite 500 Needham, MA 02494 United States.
Verastem was founded in United States.
In 2024, Verastem is currently focus on chronic lymphocytic leukemia sector.
Above is snippet of Google Trends for "chronic lymphocytic leukemia" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Verastem, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
